Hepatorenal Syndrome: Diagnosis and Treatment – newsreel –
| Autor: | Vlad Pădureanu, F Petrescu, P Mitruţ, Anca Ştefania Enescu, Aurelia Enescu, Ileana Octavia Petrescu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
renal failure
medicine.medical_specialty Cirrhosis liver cirrhosis medicine.medical_treatment Renal function Liver transplantation Chronic liver disease serum creatinine 03 medical and health sciences 0302 clinical medicine Hepatorenal syndrome Risk Factors Internal medicine Ascites medicine Humans 030212 general & internal medicine hepatorenal syndrome vasoconstrictors business.industry Prognosis medicine.disease RC31-1245 Renal pathology 030211 gastroenterology & hepatology medicine.symptom business Transjugular intrahepatic portosystemic shunt |
| Zdroj: | Romanian Journal of Internal Medicine, Vol 54, Iss 3, Pp 143-150 (2016) |
| ISSN: | 2501-062X |
| DOI: | 10.1515/rjim-2016-0024 |
| Popis: | Hepatorenal syndrome (HRS) is defined as renal failure that occurs in the presence of severe acute or chronic liver disease in the absence of underlying renal pathology. Due to the functional nature of the disease and the absence of specific diagnostic markers, HRS diagnosis is determined based on positive criteria associated with excluding other causes of renal failure in patients with liver cirrhosis and ascites. Differentiation from other types of acute or chronic renal disease is extremely difficult and therapeutic options are limited, prophylactic behavior is most appropriate in patients with severe hepatic disease and risk factors for the installation of hepatorenal syndrome. Highlighting all precipitating factors of acute renal insufficiency and therapeutic modalities in order to minimize adverse events is an important step in improving the follow-up of the patients with liver cirrhosis. The prognosis is reserved especially for type 1 HRS. Liver transplantation is the best option for patients without contraindications. The therapies introduced in recent years, such as vasoconstrictor drugs or transjugular intrahepatic portosystemic shunt are effective methods in the renal function improvement. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|